As a result, the 33-year-old pacer missed the Vipers’ next match, an Eliminator against the Sharjah Warriors. Speaking at the post-match presentation, Ferguson addressed his injury, saying, "Just a ...

India pacer Akash Deep missed the final Test of the Border-Gavaskar Trophy 2024/25 and has now revealed the length of his injury and his recovery process. Having taken five wickets in two games ...

A similar incident took place during the Bangladesh Premier League 2024-25 on Sunday. It was Bangladesh pacer Tanzim Hasan Sakib, who did a Kohli by barging shoulders with Pakistan's Mohammad Nawaz.

Shares of Nektar Therapeutics (NKTR) have been struggling lately and have lost 11.5% over the past four weeks. However, a hammer chart pattern was formed in its last trading session, which could ...

According to a report in ESPNcricinfo, Mahmood, an English pacer of Pakistani heritage, has not yet received his visa. He won't be able to join the training camp in Abu Dhabi as his passport is ...

after batter failed to make ICC Champions Trophy 2025 squad THIS Punjab Kings pacer is on verge of creating history ahead of IPL 2025, needs just 2 wickets in T20 against England to ...

Kuldeep’s return following a hernia surgery and Ravindra Jadeja’s inclusion as the last name on the team sheet instead of Mohammed Siraj, a pacer, meant the selectors have preferred only three ...

Lilly partnered with Nektar on the drug in 2017, paying $150 million upfront with another $250 million at the back end in development and regulatory milestones. It has agreed to fund 75% of the ...

Nektar Therapeutics Stock Performance NASDAQ:NKTR opened at $0.89 on Friday. Nektar Therapeutics has a 52-week low of $0.48 and a 52-week high of $1.93. The stock has a fifty day moving average of ...

With Takeda’s £46 billion acquisition of Shire, it’s been a busy year for pharma M&A – and according to analysts Datamonitor, the specialist biotechs Nektar, BioMarin and Alnylam are the ...